Elisa F. Long, Ph.D.

Affiliations: 
2008 Stanford University, Palo Alto, CA 
Area:
Operations Research, Public Health
Google:
"Elisa Long"
Cross-listing: PHTree

Parents

Sign in to add mentor
Margaret L. Brandeau grad student 2008 Stanford
 (Economic analysis of preventive and therapeutic HIV interventions.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zelenev A, Long E, Bazazi AR, et al. (2016) The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling. The International Journal On Drug Policy. 37: 98-106
Gilbert JA, Long EF, Brooks RP, et al. (2015) Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa. Plos One. 10: e0126267
VanDeusen A, Paintsil E, Agyarko-Poku T, et al. (2015) Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana. Bmc Infectious Diseases. 15: 130
Song DL, Altice FL, Copenhaver MM, et al. (2015) Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States. Plos One. 10: e0116694
Long EF, Mandalia R, Mandalia S, et al. (2014) Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom. Plos One. 9: e95735
Alistar SS, Long EF, Brandeau ML, et al. (2014) HIV epidemic control-a model for optimal allocation of prevention and treatment resources. Health Care Management Science. 17: 162-81
Long EF, Stavert RR. (2013) Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. Journal of General Internal Medicine. 28: 1294-301
Eaton JW, Johnson LF, Salomon JA, et al. (2012) HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. Plos Medicine. 9: e1001245
Long EF. (2011) HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis. Plos One. 6: e27625
Juusola JL, Brandeau ML, Long EF, et al. (2011) The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. Aids (London, England). 25: 1779-87
See more...